Biznesradar bez reklam? Sprawdź BR Plus

Podatki

  • HIMS (HIMS) Drops 5.9% to $21.13

    HIMS shares tumbled 5.9% on Tuesday, falling to $21.13 as a broad selloff hammered the specialty and generic drug manufacturing sector. The telehealth compa... The post HIMS (HIMS) Drops 5.9% to $21.13 first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 19:48

  • LFUS (LFUS) Jumps 6.0% to $349.99

    LFUS is riding a sector-wide rally. Shares of the electronic components maker surged 6.0% to $349.99 on Tuesday, March 24, 2026, as investors piled into the... The post LFUS (LFUS) Jumps 6.0% to $349.99 first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 19:57

  • Core & Main, Inc. (CNM) Q4 Earnings: Misses on EPS, Revenue Recap

    Significant earnings miss. Core & Main, Inc. (CNM) reported Q4 2025 adjusted earnings of $0.52 per share, falling well short of the $0.77 consensus estimate... The post Core & Main, Inc. (CNM) Q4 Earnings: Misses on EPS, Revenue Recap first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 19:57

  • NVIDIA (NVDA) Re-Entry Into China’s AI Chip Market: Products, Policy, Competition, and Investor Impact

    NVIDIA (NVDA) is positioning for a potential re-acceleration of data center growth by adapting its AI accelerator lineup for China... The post NVIDIA (NVDA) Re-Entry Into China’s AI Chip Market: Products, Policy, Competition, and Investor Impact first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 19:58

  • Etsy, Inc. (ETSY) Drops 6.9% to $48.81

    Etsy shares tumbled on Tuesday, falling 8.3% to $48.12 amid a broader selloff across the Internet Retail sector that dragged multiple peers into the red. Th... The post Etsy, Inc. (ETSY) Drops 6.9% to $48.81 first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 20:07

  • Surrozen 2025 Financial Results Review

    Company Overview Surrozen is a biotechnology company developing targeted therapeutics that harness Wnt signaling to address sight-threatening ophthalmic conditions. Key... The post Surrozen 2025 Financial Results Review first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 16:39

  • WeRide Inc. 2025 Financial Performance Review

    Company Overview WeRide Inc. is a global leader in autonomous driving technology and the first publicly traded robotaxi company. Key... The post WeRide Inc. 2025 Financial Performance Review first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 16:49

  • Avalo Therapeutics 2025 Financial Review

    Company Overview Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases. The company’s... The post Avalo Therapeutics 2025 Financial Review first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 17:06

  • Sutro Biopharma 2025 Financial Review

    Company Overview Sutro Biopharma is a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs). Key Financial Figures... The post Sutro Biopharma 2025 Financial Review first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 16:09

  • Arbutus Biopharma 2025 Financial Review

     Company Overview Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company focused on infectious diseases.  Key Financial Figures For the year... The post Arbutus Biopharma 2025 Financial Review first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 16:14

  • Cabaletta Bio Q4 and FY 2025 Financial Review

    Company Overview Cabaletta Bio is a late-stage clinical biotechnology company focused on developing targeted cell therapies specifically for patients with... The post Cabaletta Bio Q4 and FY 2025 Financial Review first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 16:21

  • PPHC Q4 and FY 2025 Financial Review

    Company Overview Public Policy Holding Company, Inc. (PPHC) is a global strategic communications provider offering advisory services across Government Relations,... The post PPHC Q4 and FY 2025 Financial Review first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 16:29

  • Talphera Q4 and Full Year 2025 Financial Update

    Company Overview Talphera is a specialty pharmaceutical company developing therapies for medically supervised settings. They are currently advancing their lead... The post Talphera Q4 and Full Year 2025 Financial Update first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 15:38

  • BioAge Labs 2025 Financial Results Analysis

    BioAge Labs Reports $80. The post BioAge Labs 2025 Financial Results Analysis first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 15:53

  • Heidmar Maritime Holdings Corp. (HMR) Misses Q4 EPS Estimates

    Heidmar Maritime Holdings Corp. The post Heidmar Maritime Holdings Corp. (HMR) Misses Q4 EPS Estimates first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 14:21

  • Lithium Argentina 2025 Financial Review

    Company Overview Lithium Argentina produces lithium carbonate primarily for the electric vehicle and battery markets. The company operates and holds... The post Lithium Argentina 2025 Financial Review first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 15:15

  • Context Therapeutics 2025 Financial Review

    Company Overview Context Therapeutics is a clinical-stage biopharmaceutical company developing T cell engaging bispecific antibodies for solid tumors. Key Financial... The post Context Therapeutics 2025 Financial Review first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 15:25

  • Heidmar Maritime Holdings Corp. (HMR) Q4 Earnings: Misses on EPS, Revenue Recap

    Substantial miss. Heidmar Maritime Holdings Corp. (NASDAQ:HMR) reported Q4 2025 GAAP earnings of -$0.07 per share, falling well short of the $0.03 consensus... The post Heidmar Maritime Holdings Corp. (HMR) Q4 Earnings: Misses on EPS, Revenue Recap first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 15:32

  • Hour Loop, Inc. (HOUR) Reports FY2025 Results

    Hour Loop, Inc. The post Hour Loop, Inc. (HOUR) Reports FY2025 Results first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 15:05

  • Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap

    Disappointing quarter. Sanara MedTech Inc. (SMTI) reported Q4 2025 GAAP earnings of -$0.13 per share, falling short of the $0.11 consensus estimate by 215.9... The post Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 14:08

  • LightInTheBox Holding Co., Ltd. (LITB) Reports Q4 Earnings

    LightInTheBox Holding Co. The post LightInTheBox Holding Co., Ltd. (LITB) Reports Q4 Earnings first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 13:47

  • LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings Recap

    Impressive earnings acceleration. LightInTheBox Holding Co., Ltd. (NYSE:LITB) reported Q4 2025 adjusted earnings of $0.18 per share on revenue of $63.0M, de... The post LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings Recap first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 13:50

  • Fennec Pharmaceuticals Inc. (FENC) Misses Q4 EPS Estimates

    Fennec Pharmaceuticals Inc. The post Fennec Pharmaceuticals Inc. (FENC) Misses Q4 EPS Estimates first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 13:53

  • UTStarcom Holdings Corp. (UTSI) Reports Q2 Earnings

    UTStarcom Holdings Reports Widening Loss as Revenue Slide Continues UTStarcom Holdings Corp. The post UTStarcom Holdings Corp. (UTSI) Reports Q2 Earnings first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 14:00

  • LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected

    LENZ Therapeutics, Inc. The post LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected first appeared on Alphastreet.

    AlphaStreet AlphaStreet 2026-03-24, 14:04
Biznesradar bez reklam? Sprawdź BR Plus